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The use ofpeptide antibodies in biomedical research has the major theoretical
and practical advantage that one can direct antibody production to predeter-
mined amino acid sequences, thereby obtaining site-specific immune reagents
(1). The main requirement for producingpeptide antibodies is knowledge of the
amino acid sequence ofthe protein orpart thereof. Such site-directed antibodies,
induced by immunization with synthetic peptides, have proved useful for (a)
determining the protein(s) encoded by the open reading frame ofa nucleic acid
sequence (2); (b) establishing the orientation ofproteins in the plasma membrane
(3, 4); (c) distinguishing between closely related proteins that differ by only a
single or a few amino acids (5); (d) designing immunodiagnostic reagents (6); (e)
determining the proteolytic cleavage sites of proteins (7); and (f) analyzing the
molecular basis ofvirally and microbially induced autoimmunity (8, 9).
Not all attempts to raise protein-reactive peptide antibodies have been suc-
cessful (10, 11), however, and many failures occur despite attention to selecting
amino acid sequences of appropriate size, charge, and helix formation. While
investigating the sharing of amino acid sequences between virus proteins and a
defined region of the a chain of the human acetylcholine receptor (HuAChR),
we noted (T. Dyrberg, P. Schwimmbeck, and M. B. A. Oldstone, manuscript in
preparation) that the orientation of the immunizing peptide was important for
thegeneration ofantibodies. Here we describe the immune response to the same
peptidewhen coupled through a Gly-Gly-Cys linker at either theN-or C-terminal
end, to a carrier protein. From these observations it is clear that orientation of
the immunizing peptide is one ofthe essential considerations for raising antipep-
tide antibodies.
Materials and Methods
Brief Definitive Report .
Peptide Synthesis.
￿
Peptides (Table I) were synthesized by using an automated peptide
synthesizer (430A; Applied Biosystems, Foster City, CA), and their purity was confirmed
by HPLC analysis. Peptides used for immunization were synthesized with either an N- or
C-terminal linker consisting of a cysteine residue and two intervening glycine residues as
spacers.
Immunization and Immunochemical Analysis.
￿
Peptides were coupled to a carrier protein
(KLH) via the terminal cysteine residue using m-maleimidobenzoyl-N-hydroxysuccinimide
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TABLE I
Synthetic Peptides Used as Immunogens andAntigens
Peptide name
￿
Residues
N-HuAChR160-167 CGGPESDQPDL
C-HuAChR 160-167
￿
P E S D Q P D L G G C
HuAChR 160-167
￿
P E S D Q P D L
HuAChR160-168
￿
PESDQPDLS
HuAChR 157-170
￿
A 1 N P E S D Q P D L S N F
The peptides represent sequences from the a chain of the HuAChR. Rabbits were
immunized with either N-HuAChR 160-167 or C-HuAChR 160-167, which were
synthesized with two glycine residues as spacers and an N- or C-terminal cysteine
residue through which the peptide was coupled to a carrier protein.
ester (12), and they were used for immunizing New Zealand White rabbits within 3 wk
after coupling. After obtaining preimmune sera, groups of three were immunized as
follows: on day 0, each rabbit was injected intradermally (i .d.) and subcutaneously (s.c.)
with 200 ug peptide-carrier protein in 1 ml of CFA; day 14, injected i.d./s.c. with the
same dose of coupled peptide in IFA; and on day 21, injected i.p. with 200 Wg coupled
peptide in 1 ml of an alum suspension . Rabbits were bled 14 d after the last immunization,
serum was obtained, divided into aliquots, and stored at -20'C until use.
The presence and specificity ofpeptide antibodies were tested by ELISA. Briefly, a 96-
well microtiter plate wascoated with 0.5 ug/well of peptide not coupled to carrierprotein.
Unbound reactive sites were blocked by incubation with 0.2% Tween 20, 10% FCS, and
0.5 mM thimerosal in PBS (ELISA buffer). The plates were incubated with variousrabbit
sera diluted in ELISA buffer, and unbound material was removed by washing five times
with 0.2% Tween 20 in PBS. Peroxidase-labeled affinity-purified goat anti-rabbit IgG
wasadded, and finally the plates were washed five times and substrate wasadded. Negative
controls included preimmune sera andincubations without firstand/or second antibodies.
In competition assays, selected amounts of the competing peptides were addedalongwith
the first antiserum. Finally, peptide antisera binding of AChR from Torpedo california
(kindly donated by Dr. J. Lindstrom, Salk Institute, La Jolla, CA) was tested as cited (4).
Results
Antisera from all rabbits immunized with either N-terminal HuAChR residues
160-167 or C-HuAChR residues 160-167 (defined in Table 1) reacted strongly
with the immunizing peptide, however, analysis of the N-coupled peptide anti-
serum's binding to the C-terminal peptide and vice versa demonstrated a negli-
gible crossreactivity (Fig. 1, A and B) . These results were confirmed by compe-
tition assays in which either the immunizing or the homologous free peptide was
used to inhibit binding of antibodies to bound peptide. For both groups of
peptide antisera, it was found that at a concentration where the immunizing
peptide completely inhibited binding, the homologous peptide with the Gly-Gly-
Cys linker in the opposite orientation did not decrease the binding compared to
buffer alone (Fig. 2).
To further characterize the binding properties of the peptide antisera, we
tested their reactivity with various shorter or longer peptides (Table 1). When
the eight-amino-acid core peptide, HuAChR residues 160-167, was used as
antigen, antisera to N-HuAChR 160-167 bound significantly, whereas antisera
to C-HuAChR 160-167 showed no binding (Fig. 1 C). Competition analysis
showed that HuAChR 160-167 inhibited the binding of anti-N-HuAChR 160-
167 to N-HuAChR 160-167 as effectively as N-HuAChR 160-167 itself, whereas
HuAChR 160-167 did not inhibit the binding of anti-C-HuAChR 160-167 to
C-HuAChR 160-167 (Fig. 2). The addition of a C-terminal serine residue to1346
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FIGURE 1 .
￿
Binding, in an ELISA, of peptide antisera to homologous peptides derived from
the same region of the receptor (listed in Table I) . Rabbits (n = 3) were immunized with
synthetic peptides representing the a-chain of the HuAChR positions 160-167, coupled
through either an N- or C-terminal linker to carrier protein . A, N-HuAChR 160-167 ; B, C-
HuAChR 160-167 ; C, HuAChR 160-167 ; D, HuAChR 160-168 ; E, HuAChR 157-170 ; (0)
antiserum to N-HuAChR 160-167 ; (0) antiserum to C-HuAChR 160-167 .
FIGURE 2 .
￿
Competition assay of peptide antiserum binding to the immunizing peptide in
ELISA (see Materials and Methods) . The shaded area represents binding with buffer alone .
Peptide concentration is expressed as grams per milliliter undilutedserum calculated according
to volume and dilution of first antiserum. For peptide sequences see Table I . A, inhibition of
N-HuAChR 160-167 antiserum binding to N-HuAChR 160-167 . Final serum dilution
1 :40,000 . B, Inhibition of C-HuAChR 160-167 antiserum binding to C-HuAChR 160-167 .
Finalserum dilution 1:10,000 .
HuAChR 160-167 (Table 1) resulted in a complete lack of binding of both anti-
N-HuAChR 160-167 and anti-C-HuAChR 160-167 to this peptide, HuAChR
160-168 (Fig . 1D), and in competition analysis, HuAChR 160-168 did not
inhibit the binding of either peptide antisera to their homologous peptides (Fig .DYRBERG AND OLDSTONE
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￿
Peptide antisera reactivity to native protein tested by using T. california AChR as
antigen in an ELISA. Rabbits were immunized with synthetic peptides representing the a
chain of the HuAChR, positions 160-167, either coupled throughan N- or C-terminal linker
to carrier protein. The bindinginduced by preimmune serum is subtracted. (0) antiserum to
N-HuAChR 160-167; (0)antiserum to C-HuAChR 160-167.
2). Analysis of the binding to a 14-amino-acid peptide representing the a-chain
of HuAChR 157-170, including the 8-amino-acid core sequence (Table I),
showed that antisera to N-HuAChR 160-167 bound negligibly to HuAChR
157-170, in contrast to antisera to C-HuAChR 160-167, which bound strongly
(Fig. 1 E).
With T. california AChR used as the antigen, antiserum to N-HuAChR 160-
167 did not bind (two ofthree rabbits) or bound weakly (one of three) (Fig. 3).
In contrast, the two rabbit antisera to C-HuAChR 160-167 that reacted most
strongly with HuAChR 157-170 also showed markedbindingto the T. california
AChR (Fig. 3).
Discussion
We have shown that the orientation of synthetic peptides to carrier proteins
can influence their properties as antigens. In our studies, despite close homology
between the two immunizing peptides, the resulting peptide antibodies show
very little crossreactivity (Fig. 1) owing to the amino or carboxy orientation for
peptide coupling. The pattern of binding to shorter or longer homologous
peptides suggests that immunization with the N-terminal-coupled peptide induces
antibodies reactive with the free C-terminal amino acid residue, and that their
binding depends on the identity and charge of the amino acid. In contrast,
immunization with the C-terminal-coupled peptide induces antibodies that react
with an epitope near the C-terminus ofthe peptide, and this binding is probably
conformation-dependent.
The sequence ofthe peptides used as immunogens (Table I) originates from a
region ofthe a chain of the HuAChR thought to be a major immunogenic site.
Immunization of rabbits with these peptides coupled to the carrier by either an
N- or C-terminal linker resulted in antisera that reacted with the immunizing
peptides at comparable titers. However, only antisera directed against the C-
terminal-coupled peptide reacted significantly with a peptide representing a 14-
amino-acid sequence of the HuAChR (Fig. 1 E) and with the AChR from T.1348
￿
DYRBERG AND OLDSTONE
￿
BRIEF DEFINITIVE REPORT
california (Fig. 3). Despite the binding of the anti-C-terminal antibodies to both
the extended HuAChR peptide and to the T. california AChR in an ELISA, none
of the peptide antibodies bound 1251-bungarotoxin-labeled receptor in solution
(data not shown). Thus, this region of the receptor may not be a major immu-
nogenic site.
Several events are important in determining whether a peptide antibody will
bind to the native protein from which the peptide sequence is derived. First, the
length of the immunizing peptide is critical. To raise antibodies to a peptide, a
minimum length of six amino acids is required, and peptides of>10 amino acids
generally induce antibodies that may bind to the native protein (10). Equally
important is the part of the protein from which the sequence is derived.
Antibodies raised against an accessible epitope have a better chance of binding
to the native protein than antibodies to an inaccessible site, however, the process
ofantibody binding itself may render inaccessible sites accessible. Third, as we
show here, the site where a peptide is coupled to a carrier protein is of
importance. Here we illustrate that the direction in which peptides are coupled
to carrier proteins affects the binding characteristics of the peptide antibodies,
not only with respect to the initiating peptides but also, more importantly, to the
native protein.
Our analysis ofthe binding pattern of the peptide antibodies suggests that the
immunogenic sites on the immunizing peptide may be restricted to single amino
acids. This supports the finding that individual amino acids may be epitopes,
either directly or through their influence on neighboring amino acids (5). Thus,
the immune response against short peptides results in antibodies with specificity
at the level ofthe individual amino acids. The implications ofthis conclusion are
twofold. First, finer characterization of the protein structure is possible more
than ever before, e.g., in deducing cleavage sites onprecursor molecules. Second,
the governing factor(s) in immunological tolerance to a given antigen can be
studied at the molecular level by analyzing binding ofautoantibodies to synthetic
peptides representing sequences from their natural autoantigens.
Summary
Factors known to be important in producing protein-reactive peptide antibod-
ies include the accessibility of the region from which the peptide sequence is
derived, the hydrophilic-phobic character ofthe sequence, and the length of the
peptide. The data presented here indicate that the orientation of the peptide
coupled to a carrier protein also influences the binding pattern of peptide
antibodies. An octapeptide, representing a sequence from the a chain of the
human acetylcholine receptor, was coupled either through an N- or C-terminal
cysteine-glycine-glycine linker to a carrier protein and used to immunize rabbits.
The resulting antisera reacted at comparable titers to the uncoupled immunizing
peptides, but did not crossreact with the identical but opposite-linked peptide.
Characterization of the binding to other homologous peptides showed that
immunization with the N-terminal-linked peptide induced antibodies reactive
specifically with the C-terminal amino acid(s). Immunization with the C-linked
peptide resulted in antibodies reactive with a site of the peptide near the C-
terminus.DYRBERG AND OLDSTONE
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